Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer

The aim of the present study was to determine the factors associated with reduced clinical benefits of personalized peptide vaccination (PPV) for pancreatic cancer. Phase II PPV clinical trials comprising 309 (8 non-advanced and 301 advanced-stage) patients with pancreatic cancer were conducted. Two...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Clin Oncol
Autori principali: Uchino, Yoshihiro, Muroya, Daisuke, Yoshitomi, Munehiro, Shichijo, Shigeki, Yamada, Akira, Sasada, Tetsuro, Yamada, Teppei, Okuda, Koji, Itoh, Kyogo, Yutani, Shigeru
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2021
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7788558/
https://ncbi.nlm.nih.gov/pubmed/33437477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2020.2201
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi